Cibc World Markets Corp Acquires 3,456 Shares of Teleflex Incorporated (NYSE:TFX)

Cibc World Markets Corp boosted its position in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 133.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,050 shares of the medical technology company’s stock after acquiring an additional 3,456 shares during the period. Cibc World Markets Corp’s holdings in Teleflex were worth $1,509,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the company. Kentucky Retirement Systems grew its stake in Teleflex by 1.1% during the fourth quarter. Kentucky Retirement Systems now owns 3,760 shares of the medical technology company’s stock valued at $938,000 after acquiring an additional 42 shares in the last quarter. Venturi Wealth Management LLC grew its stake in Teleflex by 33.3% during the fourth quarter. Venturi Wealth Management LLC now owns 184 shares of the medical technology company’s stock valued at $46,000 after acquiring an additional 46 shares in the last quarter. Huntington National Bank grew its stake in Teleflex by 26.5% during the third quarter. Huntington National Bank now owns 253 shares of the medical technology company’s stock valued at $50,000 after acquiring an additional 53 shares in the last quarter. KBC Group NV grew its stake in Teleflex by 1.8% during the fourth quarter. KBC Group NV now owns 3,173 shares of the medical technology company’s stock valued at $791,000 after acquiring an additional 55 shares in the last quarter. Finally, Lindbrook Capital LLC grew its stake in Teleflex by 75.3% during the fourth quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company’s stock valued at $34,000 after acquiring an additional 58 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Trading Down 2.6 %

NYSE:TFX opened at $207.09 on Tuesday. The company has a fifty day moving average of $210.40 and a 200 day moving average of $228.30. Teleflex Incorporated has a 52 week low of $177.63 and a 52 week high of $262.97. The company has a quick ratio of 1.41, a current ratio of 2.51 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $9.75 billion, a P/E ratio of 33.24, a P/E/G ratio of 2.06 and a beta of 1.16.

Teleflex (NYSE:TFXGet Free Report) last posted its quarterly earnings results on Thursday, May 2nd. The medical technology company reported $3.21 EPS for the quarter, beating analysts’ consensus estimates of $3.07 by $0.14. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. The company had revenue of $737.80 million during the quarter, compared to analyst estimates of $726.85 million. During the same period in the prior year, the business posted $3.09 EPS. The firm’s revenue was up 3.8% compared to the same quarter last year. On average, research analysts predict that Teleflex Incorporated will post 13.75 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 14th. Investors of record on Wednesday, May 15th will be issued a dividend of $0.34 per share. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.36 dividend on an annualized basis and a yield of 0.66%. Teleflex’s dividend payout ratio is currently 21.83%.

Analyst Upgrades and Downgrades

TFX has been the subject of several recent analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research note on Friday, May 3rd. Truist Financial cut their price target on shares of Teleflex from $240.00 to $219.00 and set a “hold” rating for the company in a research note on Friday, May 3rd. JMP Securities reissued a “market outperform” rating and issued a $285.00 price target on shares of Teleflex in a research note on Friday, February 23rd. StockNews.com cut shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 23rd. Finally, Royal Bank of Canada cut their price target on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a research note on Friday, February 23rd. Four analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $257.29.

View Our Latest Research Report on Teleflex

About Teleflex

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

See Also

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.